Skip to main content
B-lymphocyte depletion with rituximab and β-cell function: Two-year results
Published Web Location
http://europepmc.org/articles/PMC3898764?pdf=renderNo data is associated with this publication.
Abstract
OBJECTIVE We previously reported that selective depletion of β-lymphocytes with rituximab, an anti-CD20 monoclonal antibody, slowed decline of b-cell function in recentonset type 1 diabetesmellitus (T1DM) at 1 year. Subjects were followed further to determ
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.